In addition, when present, the percentage of PCa expressing ErbB3 in the nucleus was higher in CRPC (median 10%, range 2–95%) than in HS cancers (median 2%, range 1–20%) (p = 0.007, Mann Whitney test). This evidence concerns the gene ERBB3 and posterior cortical atrophy.